Pro Medicus AI Medical Imaging Platform Delivers $407m Pipeline as ASX Tech Stocks Slump

Pro Medicus (ASX: PME) delivered a stunning 130% profit surge in its full-year results, validating the medical software company's aggressive bet on artificial intelligence. The imaging technology group secured its second-biggest year for new contracts, building a $407m contract pipeline that sent investors rushing back to the stock. Shareholders had previously fled on fears that AI would disrupt the company's core business — instead, Pro Medicus is using AI as a weapon to...